Q1 2019 13F Holders as of 31 Mar 2019
-
Type / Class
-
Equity / @Class 'A' Ordinary Shares represented by American Depositary Shares
-
Shares outstanding
-
18,697,629
-
Total 13F shares
-
13,086,618
-
Share change
-
-106,572
-
Total reported value
-
$37,292,000
-
Price per share
-
$2.85
-
Number of holders
-
35
-
Value change
-
-$263,164
-
Number of buys
-
9
-
Number of sells
-
13
Institutional Holders of TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) as of Q1 2019
As of 31 Mar 2019,
TRINITY BIOTECH PLC - @Class 'A' Ordinary Shares represented by American Depositary Shares (TRIB) was held by
35 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,086,618 shares.
The largest 10 holders included
STONEHILL CAPITAL MANAGEMENT LLC, Paradice Investment Management LLC, JANUS HENDERSON GROUP PLC, HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC, FIRST WILSHIRE SECURITIES MANAGEMENT INC, 22NW, LP, Russell Investments Group, Ltd., HEARTLAND ADVISORS INC, Lapides Asset Management, LLC, and RENAISSANCE TECHNOLOGIES LLC.
This page lists
35
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.